1. SAT0212 Sustained Response to Mavrilimumab in Rheumatoid Arthritis Patients VIA Suppression of Macrophage and T Cells. (9th June 2015) Authors: Guo, X.; Sinibaldi, D.; Kuziora, M.; Brohawn, P.; Ryan, P.C.; Bay-Jensen, A.C.; Karsdal, M.A.; Roskos, L.K.; White, W.I. Journal: Annals of the rheumatic diseases Issue: Volume 74(2015)Supplement 2 Page Start: 734 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗